[Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis]. 2003

Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
Department of Pediatrics, Hokusetsu General Hospital.

The clinical efficacy and safety of clarithromycin (CAM) and cefdinir (CFDN) were evaluated in 65 pediatric outpatients with group A beta-hemolytic streptococcal tonsillopharyngitis. Treatment was "effective" or better in 26 (78.8%) children receiving CAM and in 27 (87.1%) receiving CFDN based on antigen clearance and the "Criteria for Evaluation in Clinical Trials of Antibacterial Agents in Children" proposed by Japan Society of Chemotherapy (p = NS). The causative organisms were eradicated in 94.7% and 93.8% of subjects in the CAM and CFDN groups, respectively (p = NS). Adverse drug reactions were limited to moderate diarrhea in one patient in each group, and subsided during treatment. Causative organisms exhibited good susceptibility to CAM and CFDN. These results suggest excellent efficacy, safety and usefulness of CAM and CFDN in the treatment of group A beta-hemolytic streptococcal tonsillopharyngitsis in children.

UI MeSH Term Description Entries
D010612 Pharyngitis Inflammation of the throat (PHARYNX). Sore Throat,Pharyngitides,Sore Throats,Throat, Sore
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077525 Cefdinir A third-generation oral cephalosporin antibacterial agent that is used to treat bacterial infections of the respiratory tract and skin. 7-(2 (2-Aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid,CI 983,CI-983,FK 482,FK-482,Omnicef,PD 134393,PD-134393,CI983,FK482
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
February 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
April 2003, Clinical pediatrics,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
January 2004, The Journal of international medical research,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
May 2007, Clinical pediatrics,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
November 1998, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
January 2008, The Turkish journal of pediatrics,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
February 2014, Indian journal of pediatrics,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
December 1992, Pediatric annals,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
August 2005, Clinical therapeutics,
Tadafumi Nishimura, and Kumiko Sugita, and Kyouji Taniguchi, and Takashi Uemura, and Yoshiaki Harada, and Minoru Kino, and Yoshirou Morikawa
September 1998, The Pediatric infectious disease journal,
Copied contents to your clipboard!